These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22255027)

  • 1. On modeling peptidomimetics in complex with the SH2 domain of Stat3.
    Dhanik A; McMurray JS; Kavraki L
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3229-32. PubMed ID: 22255027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding modes of peptidomimetics designed to inhibit STAT3.
    Dhanik A; McMurray JS; Kavraki LE
    PLoS One; 2012; 7(12):e51603. PubMed ID: 23251591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the binding of high affinity phosphopeptides to Stat3.
    McMurray JS
    Biopolymers; 2008; 90(1):69-79. PubMed ID: 18058821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.
    Park IH; Li C
    J Mol Recognit; 2011; 24(2):254-65. PubMed ID: 21360612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of potent STAT3-SH2 domain inhibitors from JAK/STAT compound library through molecular dynamics simulation.
    Manoharan S; Balakrishnan A; Hemamalini V; Perumal E
    Mol Divers; 2023 Jun; 27(3):1297-1308. PubMed ID: 35831728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening.
    Hao W; Hu Y; Niu C; Huang X; Chang CP; Gibbons J; Xu J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4988-92. PubMed ID: 18768317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.
    Resetca D; Haftchenary S; Gunning PT; Wilson DJ
    J Biol Chem; 2014 Nov; 289(47):32538-47. PubMed ID: 25288792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility.
    Kong R; Bharadwaj U; Eckols TK; Kolosov M; Wu H; Cruz-Pavlovich FJS; Shaw A; Ifelayo OI; Zhao H; Kasembeli MM; Wong STC; Tweardy DJ
    Pharmacol Res; 2021 Jul; 169():105637. PubMed ID: 33932608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors.
    Dourlat J; Valentin B; Liu WQ; Garbay C
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.
    Mandal PK; Limbrick D; Coleman DR; Dyer GA; Ren Z; Birtwistle JS; Xiong C; Chen X; Briggs JM; McMurray JS
    J Med Chem; 2009 Apr; 52(8):2429-42. PubMed ID: 19334714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.
    Coleman DR; Ren Z; Mandal PK; Cameron AG; Dyer GA; Muranjan S; Campbell M; Chen X; McMurray JS
    J Med Chem; 2005 Oct; 48(21):6661-70. PubMed ID: 16220982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.
    Mandal PK; Gao F; Lu Z; Ren Z; Ramesh R; Birtwistle JS; Kaluarachchi KK; Chen X; Bast RC; Liao WS; McMurray JS
    J Med Chem; 2011 May; 54(10):3549-63. PubMed ID: 21486047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico assessment of novel peptidomimetics inhibitor targeting STAT3 and STAT4 N-terminal domain dimerization: A comprehensive study using molecular docking, molecular dynamics simulation, and binding free energy analysis.
    Shree M; Vaishnav J; Gurudayal ; Ampapathi RS
    Biochem Biophys Res Commun; 2024 Nov; 733():150584. PubMed ID: 39208642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation.
    Namanja AT; Wang J; Buettner R; Colson L; Chen Y
    J Mol Biol; 2016 Feb; 428(3):579-589. PubMed ID: 26774853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-Based Multiplexed Assay for Identifying SH2 Domain Antagonists.
    Asai A; Takakuma K
    Methods Mol Biol; 2017; 1555():351-356. PubMed ID: 28092042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.
    Mandal PK; Ren Z; Chen X; Xiong C; McMurray JS
    J Med Chem; 2009 Oct; 52(19):6126-41. PubMed ID: 19728728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC homology-2 inhibitors: peptidomimetic and nonpeptide.
    Sawyer TK; Bohacek RS; Dalgarno DC; Eyermann CJ; Kawahata N; Metcalf CA; Shakespeare WC; Sundaramoorthi R; Wang Y; Yang MG
    Mini Rev Med Chem; 2002 Oct; 2(5):475-88. PubMed ID: 12370048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.